Industry News

BiondVax Pharmaceuticals Ltd., a clinical stage biopharmaceutical company focused on developing and commercializing a vaccine against current and future seasonal and pandemic influenza strains, today announced its second quarter 2016 financial results ended June 30, 2016 and provided a business update. Second Quarter 2016 Financial Summary. Results are in New Israel Shekels and convenience translation to US$ is provided using..."/>
BiondVax Announces Second Quarter 2016 Financial Results and Update
Endo International plc today announced that Rajiv De Silva, President and CEO, has entered into a Rule 10 b5-1 stock trading plan in connection with his year-end tax planning. Under the terms of Mr. De Silva's stock trading plan, an authorized third-party broker will sell up to 13,500 Endo shares beneficially owned by Mr."/>
Endo's President and CEO Adopts 10b5-1 Trading Plan
Cutera, Inc., a leading provider of laser and energy-based aesthetic systems for practitioners worldwide, today announced the resignation of Kevin Connors as President, Chief Executive Officer and member of the Company’ s Board of Directors effective immediately."/>
Cutera Announces Management Changes
SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it is has entered into a definitive agreement to acquire substantially all of the assets of NLT Spine Ltd., an Israel-based medical device company..."/>
SeaSpine Signs Definitive Agreement to Acquire Expandable Interbody Platform Technologies
TeamHealth Holdings Inc., a leading physician services organization, acquired Anesthesia Associates of Cincinnati and Pain Management Associates, one of the largest interventional pain medicine practices in the region. Based in Cincinnati, Ohio, AAC provides anesthesiology staffing at two hospitals, The Christ Hospital and TriHealth Evendale Hospital, and four ambulatory surgery centers, supporting a full array of surgical..."/>
TeamHealth Acquires Anesthesia Associates of Cincinnati and Pain Management Associates
Endo International plc today announced that Rajiv De Silva, President and CEO, has entered into a Rule 10 b5-1 stock trading plan in connection with his year-end tax planning. Under the terms of Mr. De Silva's stock trading plan, an authorized third-party broker will sell up to 13,500 Endo shares beneficially owned by Mr."/>
Endo's President and CEO Adopts 10b5-1 Trading Plan
Penumbra, Inc., a global interventional therapies company, today announced that its management team is scheduled to present at the following upcoming investor conferences:. An audio webcast of each presentation will be available by visiting the investors section of the company's website at The webcast will be available on the company's website for two weeks following each event."/>
Penumbra, Inc. Announces Participation at Upcoming Investor Conferences
Raptor Pharmaceutical Corp. announced today that it was named among the top workplaces in the North Bay in the 11 th Annual North Bay Business Journal competition. The results of the best places to work in the North Bay will be featured in the September 19, 2016 publication of the North Bay Business Journal.. “We appreciate this honor from the North Bay Business Journal and are incredibly proud that our employees have placed Raptor among the best places to..."/>
Raptor Pharmaceutical Voted A “Best Places to Work” Company in the North San Francisco Bay Area
Applied Genetic Technologies Corporation, a biotechnology company conducting human clinical trials of adeno-associated virus- based gene therapies for the treatment of rare diseases, today announced it has appointed Anne M. VanLent to the company's Board of Directors.. VanLent will replace Bruce Peacock on the Board, who had announced his intent to resign earlier this year.“ We thank Bruce for his valuable service to AGTC and wish..."/>
AGTC Appoints Anne M. VanLent to its Board of Directors
Cerulean Pharma Inc., a clinical-stage company developing nanoparticle-drug conjugates, today announced that it is reducing its workforce by approximately 48%, to a total of 23 full-time equivalent employees, under a plan expected to be substantially completed by the end of 2016. This workforce reduction is designed to reduce operating expenses while the company refocuses its clinical strategy for CRLX101. Affected employees are being offered severance..."/>
Cerulean Announces Reduction in Force
AtriCure, Inc., a leading innovator in treatments for atrial fibrillation and left atrial appendage management, today announced that it will present at the Morgan Stanley Global Healthcare Conference at the Grand Hyatt Hotel in New York City on Wednesday, September 14, 2016. Management is scheduled to present at 11:05 a.m. Eastern Time. A live audio webcast of the presentation may be accessed by visiting the Investors page of AtriCure’ s corporate website at..."/>
AtriCure to Present at the Morgan Stanley Global Healthcare Conference
Covalon Technologies Ltd., an advanced medical technologies company, has scheduled a conference call to be held Monday, August 22, 2016 at 9:00 a.m. EDT, to discuss the Company’ s third quarter financial results. Monday, August 22, 2016 at 9:00 a.m. EDT. To participate in the live call please dial:."/>
Covalon Announces Conference Call to Discuss Third Quarter Financial Results
Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced U.S. Food and Drug Administration approval to expand use of the Edwards SAPIEN 3 transcatheter heart valve for the treatment of patients suffering from severe, symptomatic aortic stenosis who have been determined by a Heart Team to be at intermediate risk for open-heart..."/>
Edwards SAPIEN 3 Transcatheter Heart Valve Receives Expanded Indication From FDA
Concordia International Corp.. Investors, who purchased or otherwise acquired shares between November 12, 2015 and August 12, 2016 inclusive, are encouraged to contact the Firm prior to the October 14, 2016 lead plaintiff motion deadline.. If you purchased shares of Concordia during the Class Period, please contact Joon M. Khang, Esquire, of Khang& Khang, 18101 Von Karman Avenue, 3rd Floor,..."/>
INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Concordia International Corp. and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm
Revive Therapeutics Ltd. is pleased to announce that it completed today its previously announced non-brokered private placement of units for gross proceeds of $1,500,000."/>
Revive Completes $1,500,000 Non-Brokered Private Placement
Landauer, Inc., a recognized leader in personal and environmental radiation measurement and monitoring and outsourced medical physics services, announced that its Board of Directors declared on August 17, 2016, a regular quarterly cash dividend of $0.275 per share. The dividend will be paid on October 5, 2016, to shareholders of record on September 16, 2016.. Landauer is a leading global provider of technical and analytical services to..."/>
Landauer, Inc. Declares Regular Cash Dividend
Cellectar Biosciences, Inc.. The report is available here: CLRB August 2016 Update Note. Highlights from the update are as follows:."/>
SeeThruEquity Issues Update on Cellectar Biosciences, Inc. (Nasdaq: CLRB)
Quest Diagnostics, the world's leading provider of diagnostic services, announced today that the U.S. Department of Health and Human Services has authorized the company to perform drug testing using electronic Custody and Control Forms for federally-mandated, safety-sensitive workers. With the approval, Quest becomes the largest workplace drug testing provider certified to provide Federal eCCF, which can enhance efficiencies and..."/>
Quest Diagnostics Approved to Use Electronic Drug Test Process for Federally-Mandated Workforce by U.S. Health and Human Services
CoLucid Pharmaceuticals, Inc.,, at CoLucid is a Phase 3 clinical-stage biopharmaceutical company developing lasmiditan oral tablets for the acute treatment of migraine in adults. "CoLucid's objective is to provide key information to three core stakeholder groups: prospective..."/>
King Fish Media Announces Website Launch for CoLucid Pharmaceuticals
MGT Capital Investments, Inc., announced that John McAfee, the Company's proposed Executive Chairman and Chief Executive Officer, delivered an important and well-received keynote address at the Fourth Internet Security Conference in Beijing on Tuesday, August 16, 2016 at the China National Convention Center. He was joined by more than 100 presenters representing over 70 global networks of security-related institutions and..."/>
John McAfee at the China Internet Security Conference 2016
Aphria Inc. is pleased to announce it has closed its short form prospectus offering, on a bought deal basis, including the exercise in full of the underwriters' over-allotment option. A total of 17,250,000 common shares of the Company were sold at a price of $2.00 per Share, for aggregate gross proceeds of $34,500,000."/>
Aphria Announces Closing of Bought Deal Financing
Kiwa Bio-Tech Products Group Corporation: On August 18, 2016 Kiwa Bio-Tech Products Group Corporation reported its operating results for its second quarter ended June 30, 2016. For the second quarter, Kiwa reported revenue of $443,085 and net income of $181,975. For the first six months of fiscal 2016, Kiwa reported revenue of $710,095 and net income of $238,105.. Yvonne Wang, stated, "We are pleased to see that Kiwa has achieved revenue growth and..."/>
Kiwa Bio-Tech Products Group Corporation Reports 217% Increase in 2016 Second Quarter Net Profit
DigiPath Labs, a subsidiary of DigiPath, Inc., an independent cannabis testing lab and media firm, is pleased to announce it has been selected as the laboratory testing service provider for The Clinic Nevada, LLC, a licensed cannabis cultivator, producer, and dispenser located in Las Vegas, Nevada. The Clinic has numerous retail and cultivation locations in Colorado and Illinois. The Clinic Nevada is excited to launch sub-brands, The Lab concentrates and The..."/>
DigiPath Selected as Laboratory Testing Service Provider for The Clinic Nevada
Kadimastem announced today that following success in the first stage of trials held under the agreement entered on November 24, 2015, an addendum was signed which sets out the timetable for starting feasibility studies in animals in the course of next month. The first stage involved joint trials in which optimization of the conditions was carried out and it was shown that the insulin-secreting..."/>
Following Successful First Stage in Trial: Kadimastem Signed Agreement with Medical Device Company to Expand Joint Trials of Diabetes Therapy using Unique Encapsulation Device

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Consumer Discretionary632 Articles
Information Technology609 Articles
Financials484 Articles
Industrials386 Articles
Health Care363 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at